Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome

Completed · Phase 3

Conditions studied: Keratoconjunctivitis Sicca, Sjogren's Syndrome, Lupus Erythematosus, Systemic, Arthritis, Rheumatoid, Scleroderma, Systemic

In brief

A six-month clinical research trial to evaluate the effectiveness of an investigational medication for the treatment of dry eye syndrome in patients that have been diagnosed with moderate to severe dry eye syndrome, an autoimmune disorder AND/OR females 65 years of age or older.

Key facts

Study ID

NCT00025818

Run by

Allergan

People needed

290

Starts

2001-05-01

Expected to finish

2003-03-01

Last updated by the study team

2011-05-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Eyecare of La Jolla — La Jolla, California, United States
• UCLA — Los Angeles, California, United States
• Opticare — Waterbury, Connecticut, United States
• Brandon Eye Clinic — Tampa, Florida, United States
• Emory University — Atlanta, Georgia, United States
• UIC Eye Center — Chicago, Illinois, United States
• Indiana University — Indianapolis, Indiana, United States
• Hunkleler Eye Center — Overland Park, Kansas, United States
• D'Ambrosio Eye Care — Leominster, Massachusetts, United States
• Great Lakes Eye Institute — Saginaw, Michigan, United States
• Cornea Consultants of Albany — Albany, New York, United States
• Dr. Freedman's Office — Brooklyn, New York, United States
• Dr. Wittpen's Office — Stony Brook, New York, United States
• The Cole Eye Institute — Cleveland, Ohio, United States
• Northwest Cornea — Portland, Oregon, United States
• Corona Research — El Paso, Texas, United States
• Baylor College of Medicine — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.